C07D 277/44
Acylated amino or imino radicals
C07D277/44 (Acylated amino or imino radicals) appears on 938 US grants and 799 published applications in this corpus.
Search patents in C07D- Granted patents
- 938
- Published applications
- 799
- Assignees
- 468
- Inventors
- 2,884
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 9 | 0 |
| 1978 | 22 | 0 |
| 1979 | 13 | 0 |
| 1980 | 16 | 0 |
| 1981 | 19 | 0 |
| 1982 | 17 | 0 |
| 1983 | 17 | 0 |
| 1984 | 15 | 0 |
| 1985 | 24 | 0 |
| 1986 | 17 | 0 |
| 1987 | 21 | 0 |
| 1988 | 17 | 0 |
| 1989 | 15 | 0 |
| 1990 | 15 | 0 |
| 1991 | 11 | 0 |
| 1992 | 11 | 0 |
| 1993 | 23 | 0 |
| 1994 | 14 | 0 |
| 1995 | 11 | 0 |
| 1996 | 12 | 0 |
| 1997 | 10 | 0 |
| 1998 | 8 | 0 |
| 1999 | 14 | 0 |
| 2000 | 16 | 0 |
| 2001 | 22 | 4 |
| 2002 | 17 | 22 |
| 2003 | 17 | 37 |
| 2004 | 18 | 53 |
| 2005 | 22 | 52 |
| 2006 | 19 | 49 |
| 2007 | 27 | 45 |
| 2008 | 25 | 53 |
| 2009 | 34 | 46 |
| 2010 | 34 | 66 |
| 2011 | 39 | 32 |
| 2012 | 42 | 36 |
| 2013 | 27 | 23 |
| 2014 | 33 | 29 |
| 2015 | 24 | 30 |
| 2016 | 21 | 20 |
| 2017 | 27 | 27 |
| 2018 | 16 | 25 |
| 2019 | 24 | 17 |
| 2020 | 11 | 17 |
| 2021 | 15 | 22 |
| 2022 | 13 | 20 |
| 2023 | 9 | 22 |
| 2024 | 10 | 24 |
| 2025 | 9 | 18 |
| 2026 | 8 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound having inhibitory activity against O-glusacase and use thereof28 Jul 2026US 12,692,260 B2Medifron DBT Co., Ltd.
- BAF complex modulating compounds21 Jul 2026US 12,685,735 B2Foghorn Therapeutics Inc.
- Substituted aminothiazoles as DGKzeta inhibitors for immune activation7 Jul 2026US 12,673,927 B2Deutsches Krebsforschungszentrum
- Modulators of beta catenin and uses thereof28 Apr 2026US 12,612,396 B1Dewpoint Therapeutics, Inc.
- Inhibiting USP3631 Mar 2026US 12,590,087 B2Valo Health, Inc.
- Antibacterial and synergistic active compound and use thereof27 Aug 2026US 2026/0250257 A1East China University of Science and Technology
- Usp2 inhibitors and methods of using the same for the treatment of diseases20 Aug 2026US 2026/0242394 A1Beth Israel Deaconess Medical Center, Inc.
- Amidinourea derivatives and their use in the treatment of cancer23 Jul 2026US 2026/0209196 A1Centre National De La Recherche Scientifique
- Adar1 inhibitors and methods of using the same16 Jul 2026US 2026/0200890 A1Aten Porus Lifesciences Pvt. Ltd.
- Modulators of beta catenin and uses thereof16 Jul 2026US 2026/0200909 A1Dewpoint Therapeutics, Inc.
Most cited
By later US patents
- Heterocyclic self-immolative linkers and conjugates164US 7,375,078 B2Genentech, Inc. · 2008
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Thiazolylacetamido cephalosporin type compounds148US 4,098,888 ATakeda Chemical Industries, Ltd. · 1978
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983